TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01295216 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02057250 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study NCT04240496 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT04240496 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00417417 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00417417 — Safety Biomarker (SAF): Interleukin 1
Study NCT00043979 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02519101 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00672321 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT04319107 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study NCT00941226 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02987686 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00641251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02055144 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01372904 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05210153 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04109261 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00143585 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00143585 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00152425 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00811018 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01594853 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT02027103 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT01676714 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01676714 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT01676714 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04034160 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04788355 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02964143 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02698735 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT02698735 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study NCT01385293 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01294670 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT00661531 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02414386 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT00505011 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02317120 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02317120 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02824705 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study NCT03923569 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01574729 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01877395 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01974544 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00166608 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02304367 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT04467372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00210743 — Surrogate Endpoint (SUR): Hemoglobin response rate
Study NCT03796338 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04055077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02127437 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03822845 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02003079 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01687400 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT01882881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01882881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04646759 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04646759 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03767179 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04058964 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00832507 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00225472 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00740246 — Predictive Biomarker (PRD): VIT mRNA
Genes: VIT; UNQ647/PRO1277
Study NCT04569565 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02846025 — Predictive Biomarker (PRD): ADRB3 mRNA
Genes: ADRB3; ADRB3R; B3AR
Study NCT01656408 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01721044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00871689 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06377878 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00902785 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00434564 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03136510 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03136510 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study NCT03052062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00832559 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT03833830 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00757250 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04005144 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04005144 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02256670 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00469599 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03121053 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03658681 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00326170 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04076423 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02214004 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02214004 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02214004 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02778789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01518855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00201110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01136733 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02282514 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03160989 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02379091 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05939895 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04382352 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02200237 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00518765 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT03750123 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03750123 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03750123 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01714271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03607838 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT00685945 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01258764 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04671017 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04438148 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03576937 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03576937 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03576937 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03576937 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02708667 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03841929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00400907 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00248404 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00618267 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00130663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01803607 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04289974 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01216176 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01216176 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01096069 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT01096069 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study NCT03027739 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT03027739 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02224807 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03822117 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT03822117 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT01966133 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT04336631 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02427789 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02427789 — Safety Biomarker (SAF): BDNF
Study NCT00865566 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01149291 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00624559 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00970996 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02156622 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06033079 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT03335670 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT04377230 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02626507 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT02626507 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00803569 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04069325 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00842998 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03093116 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03093116 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03093116 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT03093116 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT03093116 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT01904994 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02922140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02399176 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01834911 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02819804 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02819804 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00811772 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT04642690 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02879994 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02879994 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00379522 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00589355 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03362359 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00415610 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04071184 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT02871934 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study NCT04077138 — Predictive Biomarker (PRD): SRY mRNA
Genes: SRY; TDF
Study NCT04616456 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT03309631 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study NCT03309631 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CCR3 mRNA
Genes: CCR3; CMKBR3
Study NCT03309631 — Predictive Biomarker (PRD): CLDN1 mRNA
Genes: CLDN1; CLD1; SEMP1; UNQ481/PRO944
Study NCT03309631 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT03309631 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study NCT01255410 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04766307 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03762759 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01123863 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03368170 — Safety Biomarker (SAF): DRD3
Study NCT00981448 — Predictive Biomarker (PRD): SLC30A8 mRNA
Genes: SLC30A8; ZNT8
Study NCT01216189 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00171561 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02597946 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03105687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01890213 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03983811 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03983811 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01301027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01301027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04072900 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03168295 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02987569 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study NCT02887391 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00135551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02977195 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study NCT02738281 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT02738281 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT02738281 — Predictive Biomarker (PRD): FOXG1 mRNA
Genes: FOXG1; FKH2; FKHL1; FKHL2; FKHL3; FKHL4; FOXG1A; FOXG1B; FOXG1C
Study NCT01527773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01519297 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01871935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00078546 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT00320775 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00320775 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05266937 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05266937 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00048074 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02148380 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02640287 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study NCT00770172 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01131832 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03259009 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03259009 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04502446 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT01493453 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01493453 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04189445 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT04189445 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT03419286 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00405197 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00562549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02421445 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT03382795 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03382795 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03286842 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03213652 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03213652 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02403349 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01632722 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01632722 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02751255 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT02751255 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT02785523 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02785523 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05272800 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01886846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02503137 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT00557713 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03029000 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06618846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06618846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06618846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00181181 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04269226 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01771835 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00253630 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT01780831 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT05589467 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03593746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00772122 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00426608 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04232579 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04232579 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04232579 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03604770 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00420199 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00001507 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01850212 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01121393 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01954134 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01954134 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04111029 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04111029 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04244656 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT00461357 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL